These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 6188805

  • 1. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
    Niklasson F, Agren H, Hällgren R.
    J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
    [Abstract] [Full Text] [Related]

  • 2. Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF.
    Agren H, Osterberg B, Niklasson F, Franzén O.
    Biol Psychiatry; 1983 Jun; 18(6):635-49. PubMed ID: 6191784
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism.
    Joborn C, Hetta J, Niklasson F, Rastad J, Wide L, Agren H, Akerström G, Ljunghall S.
    Psychoneuroendocrinology; 1991 Jun; 16(4):311-22. PubMed ID: 1720895
    [Abstract] [Full Text] [Related]

  • 4. Brain purinergic activity linked with depressive symptomatology: hypoxanthine and xanthine in CSF of patients with major depressive disorders.
    Agren H, Niklasson F, Hällgren R.
    Psychiatry Res; 1983 Jul; 9(3):179-89. PubMed ID: 6578531
    [Abstract] [Full Text] [Related]

  • 5. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns.
    Agren H.
    Psychiatry Res; 1980 Oct; 3(2):211-23. PubMed ID: 6171840
    [Abstract] [Full Text] [Related]

  • 6. CSF monoamine metabolites of depressed patients during illness and after recovery.
    Träskman-Bendz L, Asberg M, Bertilsson L, Thorén P.
    Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
    [Abstract] [Full Text] [Related]

  • 7. CSF amine metabolites and depression.
    Peabody CA, Faull KF, King RJ, Whiteford HA, Barchas JD, Berger PA.
    Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
    [Abstract] [Full Text] [Related]

  • 8. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 May; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 9. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L, Wiberg A, Asberg M, Träskman L, Sjöstrand L, Thorén P, Bertilsson L, Tybring G.
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [Abstract] [Full Text] [Related]

  • 10. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
    Rosenthal NE, Davenport Y, Cowdry RW, Webster MH, Goodwin FK.
    Psychiatry Res; 1980 Mar; 2(1):113-9. PubMed ID: 6158064
    [Abstract] [Full Text] [Related]

  • 11. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF.
    Psychiatry Res; 1979 Oct; 1(2):131-9. PubMed ID: 95232
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Ogawa S, Tsuchimine S, Kunugi H.
    J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
    [Abstract] [Full Text] [Related]

  • 13. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J, Pinder RM, Stulemeijer SM, Van Dorth R.
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [Abstract] [Full Text] [Related]

  • 14. Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.
    Banki CM, Molnar G, Fekete I.
    Arch Psychiatr Nervenkr (1970); 1981 Sep; 229(4):345-53. PubMed ID: 6164353
    [Abstract] [Full Text] [Related]

  • 15. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

  • 16. CSF monoamine metabolites in melancholia.
    Asberg M, Bertilsson L, Mårtensson B, Scalia-Tomba GP, Thorén P, Träskman-Bendz L.
    Acta Psychiatr Scand; 1984 Mar 12; 69(3):201-19. PubMed ID: 6201041
    [Abstract] [Full Text] [Related]

  • 17. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R, Roos BE, Kampman R, Hyyppä S, Ranta P, Myllylä V.
    Ann Clin Res; 1979 Feb 12; 11(1):25-9. PubMed ID: 453776
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E, Westberg P, Alling C, Thuresson K, Modigh K.
    Psychiatry Res; 1991 Mar 12; 36(3):243-51. PubMed ID: 1712114
    [Abstract] [Full Text] [Related]

  • 19. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L, Asberg M, Lantto O, Scalia-Tomba GP, Träskman-Bendz L, Tybring G.
    Psychiatry Res; 1982 Feb 12; 6(1):77-83. PubMed ID: 6173891
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD, Geracioti TD, Altemus M, Kling MA.
    Biol Psychiatry; 1982 Feb 12; 33(8-9):636-41. PubMed ID: 7687151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.